Abstract:Purpose Recent studies have suggested the significant relationship between follicle-stimulating hormone (FSH) and non-alcoholic fatty liver disease (NAFLD) in postmenopausal women. However, it is unknown whether FSH impacts the risk of NAFLD in men. This study aimed to investigate the association between serum FSH levels and NAFLD in elderly Chinese men aged 80–98, a particular group with worse outcomes of NAFLD. Patients and methods A cross-sectional analysis was performed in 444 subjects in a geriatric health center. The highest quartile of serum FSH was used as reference. Hepatic steatosis was defined according to the results of liver ultrasound. Fibrosis-4 (FIB-4) Index > 2.67 was defined as advanced fibrosis. Results Based on liver ultrasound, 108 (24.3%) subjects had NAFLD. FSH level were negatively correlated with total testosterone, estradiol, nutritional risk, and the prevalence of high education level (all P < 0.01), and positively correlated with age, luteinizing hormone, alanine aminotransferase and aspartate aminotransferase (all P < 0.05). The correlation between FSH and body mass index or antihypertensive drug usage was marginally significant ( P = 0.057; P = 0.066, respectively). The percentage of subjects with NAFLD had a trend to increase following the quartiles of serum FSH (20.0% in quartile 1, 18.2% in quartile 2, 27.3% in quartile 3, and 31.6% in quartile 4). After adjustment for common pathogenic risk factors, nutritional risk, and other sex hormones, serum FSH were progressively associated with odds ratios for NAFLD. The adjusted odds ratios and 95% CIs for quartile 1, quartile 2, and quartile 3, compared with quartile 4 were 0.132 (0.034–0.516), 0.190 (0.052–0.702), and 0.404 (0.139–1.173), respectively. Obesity was not involved in the potential negative role of circulating FSH on the risk of NAFLD in our population. Furthermore, our results revealed no significant association between FSH and advance fibrosis, the OR (95% CI) for advanced fibrosis was 1.018 (0.983–1.054) ( P = 0.316) after adjusting for the potential covariates, although a positive correlation of FSH and FIB-4 score was observed ( r = 0.325, P = 0.001). Conclusion Low FSH level may decrease the risk of NAFLD in elderly Chinese men. These findings warrant replication in more extensive studies.

Associations between serum total, free and bioavailable testosterone and non-alcoholic fatty liver disease in community-dwelling middle-aged and elderly women

Association Between Serum Free Fatty Acid Levels and Nonalcoholic Fatty Liver Disease: a Cross-Sectional Study

Serum vitamin D levels are inversely related with non-alcoholic fatty liver disease independent of visceral obesity in Chinese postmenopausal women.

Relationship Between Alanine Aminotransferase Levels and Metabolic Syndrome in Nonalcoholic Fatty Liver Disease

ASSA13-10-11 Nonalcoholic Fatty Liver Disease is Associated with Subclinical Atherosclerosis

Relationship between Nonalcoholic Fatty Liver Disease and Abnormality of Glycolipid Metabolism

Associations Between Sex Hormones and Metabolic-Associated Fatty Liver Disease in a Middle-Aged and Elderly Community.

Association Between Thyroid Function and Nonalcoholic Fatty Liver Disease in Euthyroid Elderly Chinese

A study on the association between nonalcoholic fatty liver disease and the levels of sex hormones among patients with type 2 diabetes mellitus

Low serum sex hormone-binding globulin is associated with nonalcoholic fatty liver disease in type 2 diabetic patients.

Sex-specific Metabolic Risk Factors and Their Trajectories Towards the Non-Alcoholic Fatty Liver Disease Incidence.

Combined Association of Vitamin D and Sex Hormone Binding Globulin with Nonalcoholic Fatty Liver Disease in Men and Postmenopausal Women A Cross-Sectional Study

Follicle‐stimulating Hormone is Associated with Non‐alcoholic Fatty Liver Disease in Chinese Women over 55 Years Old

Association analysis between serum sex hormone-binding globulin (SHBG) and nonalcoholic fatty liver disease (NAFLD) in elderly patients with type 2 diabetes

The associations of total testosterone with probable nonalcoholic steatohepatitis and nonalcoholic fatty liver disease fibrotic progression in men with type 2 diabetes: a cross-sectional study

The association between serum testosterone levels and metabolic syndrome among women

Association of sex hormones with non‐alcoholic fatty liver disease: An observational and Mendelian randomization study

Association Between Nonalcoholic Fatty Liver Disease and the Risk of Cardiovascular Disease in the Middle-Age and Elderly Population of Northern China: A Cross-Sectional Study

High-free Androgen Index is Associated with Increased Risk of Non-Alcoholic Fatty Liver Disease in Women with Polycystic Ovary Syndrome, Independent of Obesity and Insulin Resistance

A Low Follicle-Stimulating Hormone Level is a Protective Factor for Non-Alcoholic Fatty Liver Disease in Older Men Aged over 80

Free triiodothyronine is associated with the occurrence and remission of non-alcoholic fatty liver disease in euthyroid women.